Antibodies for clinical samples
Ended Purchase Order Awarded Last action
- Contract number
- 75N91019P00370
- Awardee
-
Biolegend, Inc. UEI WVJUG294HEM6
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $22,895
Award facts
- Contract value 100% obligated
- $22,895.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325414 Biological Product (except Diagnostic) Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- San Diego, CA 92121, USA
Award details come from SAM.gov/FPDS.
About this award
The National Cancer Institute awarded a purchase order to Biolegend, Inc. for $22,895 in antibodies for clinical samples on May 21, 2019, with completion scheduled for July 21, 2019. Work is performed in San Diego, California. The order is priced on a firm fixed price basis with no set-aside category applied.
Quick answers
Who was awarded contract 75N91019P00370?
75N91019P00370 was awarded to Biolegend, Inc. by National Cancer Institute (National Institutes of Health) on May 21, 2019.
How much is contract 75N91019P00370 worth?
The government has obligated $22,895 on 75N91019P00370.
Was contract 75N91019P00370 competed?
The extent of competition for 75N91019P00370 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award